Researchers Utilize Stem Cells to Study Parkinson’s Disease

Stem Cells could lead to personalized treatments for diseases involving genetic mutations

Recently, researchers team from Sanford-Burnham’s Del E. Webb Center for Neuroscience, Aging, and Stem Cell Research and MIT’s Whitehead Institute for Biomedical Research used stem cells from patients with Parkinson’s disease to show that a genetic mutation is partly responsible for cell death in the patients’ nervous system.  This study exhibits a novel ability of stem cells to act as a model through which researchers can better understand diseases and develop better outcomes.

The use of a patient’s own stem cells to study diseases opens the window to individualized treatments to give each patient the best possible outcome. With the ability to determine whether a genetic mutation is involved in a particular disease, researchers can progress towards more effective treatments for the mutation, rather than the symptoms.

To learn more about stem cells and how to insure access to emerging personalized regenerative treatments by banking your own valuable stem cells, please visit StemSave or call 877-783-6728 (877-StemSave) today.

To view the full article, click here.

 

The Future of Regenerative Medicine is Now™.